Im V-tox
NDC Package 70514-0011-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Im V-tox is 1) Open the pouch and take the patch out. Marketed by Karatica Co., Ltd, this product is identified by NDC 70514-0011 and is authorized under FDA application part347.

Identification & Billing

NDC Package Code
70514-0011-1
Package Description
5 POUCH in 1 PACKAGE / 13 g in 1 POUCH
Product Code
11-Digit Billing Format
70514001101

Clinical Specifications

Proprietary Name
Im V-tox
Dosage Form
-
Usage Information
1) Open the pouch and take the patch out. Then remove the transparent film.2) Center the patch on your chin. Then hang the earloop on both ears after gently stretching the patch to fit your face.3) Remove the patch after 15~20 mins, then gently pat to finish. *Tip: Recommend to use 2~3 times a week. Use daily for better results.

Regulatory & Marketing

Labeler Name
Karatica Co., Ltd
FDA Application #
part347
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
03-16-2018
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70514-0011-1 identifies a specific commercial package of 5 pouch in 1 package / 13 g in 1 pouch of Im V-tox, labeled by Karatica Co., Ltd. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Karatica Co., Ltd on March 16, 2018. The current certification is valid through December 31, 2020.

How is this Karatica Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70514001101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70514-0011-1
11-Digit CMS (5-4-2)
70514-0011-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.